Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer

Clinical trial NCT00065182 · COMPLETED

Trial details

NCT number: NCT00065182
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer, Non-Small Cell Non-Small-Cell Lung Cancer

Start date: 2003-08-14
Primary completion: 2007-08-30
Enrollment: 399

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.